word,tfidf
day,1.6008475430108853
gvhd,1.5015856158299383
uveitis,1.3578011038441136
trial,1.3084474270343758
msc,1.16871539558747
disease,1.168488239387532
haplo,1.1233453898599655
transplant,1.1003866470914574
days,1.0936027215698239
cell,1.0516790335993553
bd,1.0495163211340088
clinical,1.0448332719882631
transplantation,1.0039354568702747
week,0.9339425686226326
al,0.9009163453322243
hsct,0.8856739267426628
donor,0.872421256162259
prevalence,0.8254019335599316
non,0.8240268952404131
et,0.8128115075906737
response,0.8074228230669999
refractory,0.7963575801031759
12,0.7867738616829651
randomized,0.7802915187766172
blood,0.7772069323948717
weeks,0.7733586231914378
dose,0.7643412683448557
cells,0.7630744990582002
antibiotic,0.75952245987099
mg,0.7575367767498041
post,0.755712012629064
severe,0.755335982278122
kg,0.7521327878716213
anti,0.7392068204515886
subjects,0.7367531746717783
prior,0.7316030187513887
relapse,0.7114337713319898
active,0.7064393280263619
acute,0.7010797874791505
stem,0.694810743238943
efficacy,0.6932307066175617
vasculitis,0.6861164543327574
conditioning,0.683420863420126
cd,0.6787621092438058
duration,0.6692070574026514
survival,0.6660910005040945
therapy,0.6616614104738701
sct,0.6571211018666386
rate,0.6422799320091342
arm,0.6416067157129786
graall,0.616571745980406
allogeneic,0.6136639353691026
adalimumab,0.6109165922195233
defined,0.6108076551986344
ks,0.607619777864406
pd,0.6069107830212641
ptcy,0.6045661155622148
according,0.5949077016359383
related,0.5898080305551079
hla,0.5835200060928976
matched,0.5829584337184882
infection,0.5744364268892495
period,0.571830548453726
including,0.5701200003192425
placebo,0.5694072698569269
use,0.5608164055750609
increased,0.5550463957705694
covid,0.5530270281285234
injection,0.5515572430098593
treated,0.551429667747203
19,0.5441919483437345
m6,0.5364149946729008
using,0.5358615338444094
activity,0.5286046254685525
unrelated,0.5234537634731521
oral,0.5214919496441592
grade,0.5195932565997036
safety,0.5163629778010563
hospital,0.5132076328208535
m12,0.5040154337555999
evaluate,0.5037018253129127
cyclophosphamide,0.5020743036969032
hospitalization,0.5008280711266279
effects,0.4965743916841371
breast,0.4948397796595978
results,0.4936096173022237
year,0.493545164352437
14,0.49223787781143874
negative,0.49183882836050513
90,0.4898529736839774
following,0.48847988623523714
regimen,0.48777923858642497
overall,0.48642499487887647
rituximab,0.48493471389925835
new,0.48336762409519474
belimumab,0.4811410936201444
systemic,0.4794276321989808
reported,0.47833813187529856
m3,0.4783187633385905
chronic,0.4732075496061573
stage,0.47152818399606605
group,0.47113596404078306
tumor,0.4689853377892623
research,0.46867752491864756
mud,0.4666841808320449
16,0.46074727694306944
drug,0.46056593512306593
randomization,0.45908722611606123
prednisone,0.4563930615183159
ph,0.45619632123457904
endpoint,0.454036962694633
21,0.4474697193212005
incidence,0.446129323999716
complete,0.44317289526590753
failure,0.4416699836733458
tocilizumab,0.4413414311733076
fludarabine,0.43933468525283736
treosulfan,0.438677158322584
life,0.4374903040332337
score,0.4360497635083288
graft,0.4347709205984442
marrow,0.4322828436135285
high,0.43084148217512447
20,0.4297335637381461
immune,0.42972600751018464
tnf,0.4284202703777851
used,0.42526158371231726
anemia,0.42503938593949486
care,0.42388343792370103
aes,0.42260134759010626
remission,0.4220924834149114
data,0.4203671223971206
effect,0.4197081644578905
24,0.4183783387143712
ii,0.4165772771750318
events,0.41589754418991365
visit,0.4154001865779283
identical,0.41361359357571836
free,0.40762764501849474
pediatric,0.40756897175871526
versus,0.4038386418466181
adverse,0.40186641745944407
15,0.40170617399034886
associated,0.40156146249797403
prophylaxis,0.39971005805838417
40,0.3975972408643302
saa,0.39542692775991806
50,0.3944773070318838
involvement,0.3939924194970038
cancer,0.39090719168001714
hours,0.38942589082032353
history,0.38675645668818937
standard,0.3855297344879913
performed,0.38516511831053235
administration,0.38307289423107443
compared,0.38084849317361347
22,0.38053771898046174
function,0.3774964864769637
ocular,0.3774268450316547
leukemia,0.37620275628080513
atg,0.3759302558126214
48,0.3735013473971019
specific,0.3733900338433955
retinal,0.3722198151792632
lesions,0.36995845524511367
infectious,0.3689675601138498
test,0.36817054306764935
main,0.3649140045554601
based,0.36477068891373976
studies,0.36320848702776865
best,0.36290494626926767
evidence,0.36279448242281076
major,0.36062932398287073
2005,0.357040102656197
immunosuppressive,0.355415354401731
corticosteroids,0.3542918007620636
eye,0.35358228595277125
aplastic,0.35357738516331944
adult,0.35217778892887996
imaging,0.34477691919384945
behcets,0.34408197105554694
36,0.34402578284153684
pembrolizumab,0.34266225743873074
participants,0.3413441203300111
iv,0.3367976379554572
effective,0.33596086201600484
groups,0.3347687078729667
age,0.3335786858269288
risks,0.33190633339341563
quality,0.3318434169184598
baseline,0.3318140036389928
conventional,0.3310725450317582
decreased,0.3302999327698759
mortality,0.33007379152567096
obtained,0.32907381212505943
management,0.3282023559726288
available,0.32774879071132346
profile,0.32693457130758996
endpoints,0.3268354924836886
observed,0.3255090479790936
time,0.32390101964170076
infections,0.32138971018210405
complications,0.31999272877255813
protocol,0.3190205343049224
drugs,0.31877722663611624
treatments,0.31847442427456457
classic,0.3171555144681357
endemic,0.3171555144681357
approach,0.31541799351910205
extension,0.3152758387670035
2003,0.31515364785635275
hematopoietic,0.3145874090892706
informed,0.3128409892150019
m24,0.312702277583462
monoclonal,0.31175080839218017
skin,0.3117266094965235
compare,0.31139541108425184
70,0.31136921121816896
25,0.31069831803143094
28,0.3105172262982285
prospective,0.30988311318108724
reduced,0.3096988884988929
ml,0.30958054821216624
antibodies,0.3066689896691141
responders,0.3062283025219778
term,0.30555654225286266
assessment,0.30472268244546247
syndrome,0.3033097751651586
sample,0.3021747299180559
trials,0.3020956221198964
infusion,0.30168855944726586
centers,0.3013856009490345
ultrasound,0.3000826203976998
louis,0.2995426975515746
center,0.2991138348028902
classification,0.297072332677488
investigational,0.295906468548496
mismatch,0.29536676211691215
renal,0.29527840380977005
niu,0.29508564564577866
levels,0.2940881851713042
reduction,0.29283710844202665
recently,0.2922477468088506
haploidentical,0.2921892728220501
having,0.29026677938519757
saint,0.28911578662095916
comparing,0.288942129578061
toxicity,0.28822749587609103
potential,0.2881242252283881
long,0.28793438747068856
assess,0.28786305373164367
daily,0.287323266370979
received,0.2872600665406398
inflammation,0.28676278384848886
ap,0.28623466679040616
gene,0.28494495540023423
mycophenolate,0.28413943622427595
m1,0.28335930393626335
organ,0.28293555504604967
cutaneous,0.2819247376604421
ist,0.28094229784803953
health,0.27996964749166897
respiratory,0.27968036400208307
cases,0.2796748977621685
80,0.27830840879117397
60,0.27826027851761037
biomarkers,0.2780338122253539
case,0.27684910202750235
virus,0.27638499795380955
women,0.27531982403536764
methods,0.27519739283804207
nausea,0.27476045470817334
macular,0.2737439000374441
records,0.27331170105867186
lung,0.27306576894281726
assessed,0.27295438168479796
additional,0.2723722566352626
rates,0.2722747278012746
subject,0.27220102892246534
interventional,0.2715844216178635
l1,0.2712394375600051
optimal,0.27119875879825883
2019,0.27111952571121506
corticosteroid,0.27097831729005883
agent,0.269844153796685
progression,0.2695181876499557
simons,0.26920644808052957
hp,0.2688315835561326
death,0.2686045459772222
mofetil,0.2683501975920398
sepsis,0.268149718884111
inspired,0.2679235594497567
requiring,0.267653986147597
injected,0.26731432366987945
current,0.26729822077311705
biological,0.26666665939275885
pulmonary,0.2664011740099471
100,0.2661937649464211
therapeutic,0.2661616664987472
size,0.2658789936766814
resistant,0.2646786739188937
aged,0.26425762580441564
cure,0.2628735576212555
bone,0.2619980185537045
confirmed,0.2617528525064431
fatigue,0.2616965822432445
site,0.2612519187510029
national,0.26068360479062336
cardiac,0.2606715234149985
45,0.26039688104911385
tolerance,0.2603360342094561
antibody,0.2603297086067991
sarcoma,0.2601631645737513
05,0.2600913117623832
concentration,0.2596141336899211
poor,0.25937054460710995
donors,0.25891797088618973
adults,0.2582798943135839
experimental,0.2575225494881015
carcinoma,0.2563347015783905
11,0.2561623487272426
benefit,0.25606745561568817
arms,0.25572508457535986
therapies,0.2556071271151364
peripheral,0.2553143293630224
m2,0.2539319874348679
human,0.25312444657629624
positive,0.2530537276812862
creatinine,0.2530155207823951
met,0.2523518081526092
transfusion,0.2522532320388253
french,0.2521547994838694
busulfan,0.2521505576385457
pain,0.251952808370638
known,0.25188706895464213
observational,0.2516162150257188
host,0.2513064922794088
pcr,0.24959410756435182
scientific,0.24958636795601238
lupus,0.24955999853297556
aminotransferase,0.24916092070218152
engraftment,0.2481095997926822
transfusions,0.24810461346413984
previous,0.24734401401038694
ratio,0.24717850403697744
line,0.24681944190473176
infliximab,0.2466760917002572
m0,0.2464918894790987
changes,0.24488285978947258
106,0.24451705321493022
aa,0.24281430160470716
sites,0.24248137627643843
13,0.24235592349728508
level,0.2418990438266434
outcomes,0.2413909966888024
digital,0.24127235615542608
increase,0.24031291198782304
multicenter,0.2403064332528322
signs,0.24028599505104564
absence,0.24021277983038009
serum,0.24018210441785587
similar,0.23968769307664822
considered,0.2389823727173276
posterior,0.237594124744991
receiving,0.23756397827425055
occurrence,0.23689540683939228
end,0.23568915582188402
monitoring,0.23557928222020333
acquired,0.23501323515291336
inflammatory,0.23408922607167454
higher,0.23384401233757754
reconstitution,0.23310951209987438
m9,0.23300457886942197
transplanted,0.23273832755131607
statistical,0.23258850647863488
control,0.23229119989028071
mri,0.2321402594694485
threatening,0.2317355166167548
outcome,0.23159377757668784
viral,0.23158767219904622
contraception,0.2305599307491774
include,0.23039906778444585
disorders,0.2303237731806381
red,0.23021526189640987
multi,0.23021351789203853
myeloablative,0.2297097977091918
tumors,0.2296472358209601
sparing,0.22957100472378159
terms,0.22923814071372825
agents,0.22887622771747743
rash,0.22831625756584503
option,0.22731156622483206
old,0.22641494550231728
strategy,0.2260778036137985
urinary,0.22545610283033946
ciprofloxacin,0.22542751148148543
vascular,0.22507627858452944
combination,0.224323345910608
sibling,0.22413527527281155
philadelphia,0.22403709458768944
regardless,0.22375954144680077
demonstrated,0.2230839251009872
partial,0.2230187358542489
abnormalities,0.22299453598838773
overload,0.22244532199806327
pregnant,0.222265688870362
showed,0.22190569451016295
event,0.22138440525260655
intensive,0.22130311190508914
change,0.220999811533269
france,0.2208364461979836
centre,0.22076241475086594
evaluated,0.22004504124587537
intensity,0.21996986676928035
suspected,0.21988233956431677
kidney,0.2188382677674339
selection,0.21809522973942394
uncontrolled,0.21750276600767116
steroid,0.21739763687921768
intestinal,0.21729604368477984
tb,0.21723259813145232
improvement,0.21713864083239884
prognosis,0.21706598393756962
sensitivity,0.2166480896764435
need,0.2157776862202014
factors,0.21548406472826306
orally,0.21502570333496202
17,0.21501766434913347
immunosuppression,0.21480047274817107
lymphoma,0.2146548333617391
median,0.21455858015414211
better,0.21451731506253782
antibiotics,0.21450368187057556
probability,0.21427675811337624
participation,0.21405278184096457
pre,0.21309531303721255
visual,0.21278905159532868
different,0.21259964728626563
300,0.21253382995754927
product,0.2118482335610029
diagnosis,0.21179731176863706
medical,0.21164060146893426
iron,0.21129554401017264
source,0.2111016687239195
evaluation,0.21073713955563017
melanoma,0.21073382079228653
department,0.21032794111745196
mscs,0.2103040943611095
treat,0.2093305091509747
diarrhea,0.20831156287522196
type,0.20806918402768948
reference,0.2080207168680289
early,0.20795837729790242
administered,0.20793746807511296
fertility,0.20789083278045184
controlled,0.20783554329217707
induction,0.20689985868615118
justification,0.20555802914977214
significant,0.20503141039481845
nrm,0.20502333357044714
phrc,0.20497404599800034
currently,0.204643621856855
grfs,0.2045543305009086
hepatitis,0.2042236312155197
comparison,0.20361425310415618
present,0.20337726461663394
iii,0.2029456306720747
vomiting,0.2022929228707811
scale,0.20212460976905808
receive,0.20200181787529065
followed,0.20111455240009724
oedema,0.2006534689396129
pregnancy,0.20048012740301682
complicated,0.2002401373748569
eligible,0.19953002355704774
adenocarcinoma,0.1990282478211855
anterior,0.19821074689671173
globulin,0.19725348918323768
shown,0.1970778012874704
chemotherapy,0.19672736494414875
international,0.19665694690970803
underlying,0.1964877855684665
subcutaneously,0.19645829993277672
metabolic,0.19623169130792129
ci,0.19601992329674983
older,0.19515741411793572
clinically,0.19513555577097932
35,0.19487207330856438
contraceptive,0.19457651575770255
good,0.19369765323363952
presence,0.19366976464114086
evolution,0.19350578094436105
short,0.1934860509817635
hypersensitivity,0.19270537881371705
independent,0.1925658452487904
cd20,0.19214784886817943
promising,0.19211735168794625
il,0.1921138979082522
heart,0.19172135059854156
thiotepa,0.19150636487886913
bilirubin,0.19115135423240937
edema,0.19113242002227662
children,0.19095531856407133
despite,0.19087697443497384
radiation,0.190678880200417
injectable,0.1906651615472893
dependency,0.18966264991989104
signed,0.1895019912379311
liver,0.18925884114572847
social,0.1890164884469388
plasma,0.1885497827163679
irradiation,0.18834324016479612
diagnostic,0.18832100357471407
estimate,0.18794188262911363
42,0.18766911002300318
initial,0.18766580363339772
stopped,0.18755315662305694
medicinal,0.18726112844083043
inhibitor,0.187175042365614
doses,0.18716762252397248
single,0.18711734475438513
os,0.18679169370696624
initiation,0.1863123577477743
worsening,0.186303132024536
exclusion,0.18595496749651133
2016,0.18549986790388917
symptoms,0.18521865323336606
intravenous,0.18482136124379855
2012,0.18436581286650466
anakinra,0.18431878981200583
required,0.18299655196723436
samples,0.1829195660392004
second,0.18218458712923796
female,0.18201863300394924
biopsies,0.18188949027799353
chimerism,0.1817100767431244
pr,0.18169908258376133
procedure,0.18158944034441207
abstinence,0.18145117391174698
appendix,0.18102180901497092
95,0.1807643193447597
lymphoblastic,0.18015062972562218
role,0.18011793971348208
equivalent,0.17990395192370584
acronym,0.17986051981601797
exposed,0.17911521935975824
immunomodulatory,0.1790110753004757
common,0.17895759995784571
minimal,0.17853630485535837
stenosis,0.17830994529908795
hiv,0.17819200346555483
benefits,0.17772734172509305
method,0.17764839622374384
impact,0.1767043020782429
mmhg,0.1766584081472764
funding,0.17627226947411714
manifestations,0.17619588832670177
persistent,0.17585095848469823
proportion,0.17556573467619743
usual,0.17525866820698832
date,0.17520436836542116
protein,0.17515049900556665
count,0.1751382570905635
vs,0.17480718655628855
mds,0.17456055779394672
5mg,0.17437192044009628
myeloid,0.1737313335315737
value,0.17353004997187518
cellular,0.17346425628345064
tract,0.1733963166605401
tomography,0.17311014882979853
dysfunction,0.17309658114026638
mean,0.17286118648438376
steroids,0.1727010861597192
reduce,0.17244118491465335
planned,0.1719226091777299
central,0.17155539294023361
past,0.17073320936662248
icu,0.17060853722328778
expression,0.1705656399195467
mrd,0.17044582692032795
late,0.17019413284993415
low,0.17017113014915297
psychiatric,0.169408725084952
recipient,0.1691924721303696
status,0.1690235364862485
responses,0.16846689973857742
replacement,0.16827821352369107
23,0.16808534021360774
individuals,0.16783019443135744
emergency,0.16764631138827057
mm3,0.1674849862044431
asthenia,0.16676979692580718
insurance,0.16665171389369768
given,0.1666109349685771
sun,0.1660869895540331
unit,0.16606582978895942
costs,0.1658120284378207
recommended,0.16571524446565258
head,0.16417913489554917
hopital,0.16404981068928676
ric,0.163947039380714
sexual,0.16392766107155218
umbilical,0.16341733360930782
correlation,0.1633238364536065
recent,0.1630958064915651
advanced,0.16284553557381695
continued,0.16276764692608903
context,0.16274594843587564
double,0.1625228011124532
childbearing,0.16249986124712446
aml,0.16242602802437633
prevent,0.1622660075558592
solution,0.16208058354579613
cd8,0.16167663520726752
allows,0.16141484750001364
hormonal,0.16138983665414391
interventions,0.16120359401781803
resolution,0.1609687058413311
small,0.1609094141829935
previously,0.16087870454736197
place,0.16078209738257396
33,0.16069156932532547
derived,0.16059469678034277
body,0.1603710562282289
respectively,0.15976050875864195
highly,0.15961744719189228
dosage,0.15948824793662114
power,0.15942004397195483
setting,0.15920277413081754
tissue,0.1586576023789975
antigen,0.15862986772769846
enrolled,0.1583402184614069
inferiority,0.15745679507018723
improve,0.156913435421774
course,0.1568967523429768
injections,0.15677074082737272
reaction,0.15675665111908413
cumulative,0.15651700813976163
180,0.15636576498265609
baltimore,0.15630957650541025
mutations,0.15579273452111447
able,0.1557634109596644
clearance,0.15568853518582138
weight,0.15532132034373328
program,0.15527405718640527
multiple,0.15515193028815347
ebv,0.1549603343007955
legal,0.15448280807267187
reducing,0.1544697836276875
cervical,0.15343826915520328
left,0.15341988384007246
described,0.15339564761560825
pneumonia,0.15321866559602676
min,0.1532014626283261
disorder,0.15295925576454894
demonstrate,0.15272731519545227
2020,0.1526251690339641
26,0.15258869960023808
lines,0.15251702581054674
neurological,0.15233400342971676
2014,0.1518874301317195
aims,0.1514789970752175
analyses,0.15147798255165182
measured,0.1512771837240488
tuberculosis,0.15110824567525874
maximum,0.15107899960949503
participate,0.1509441344843814
biologic,0.15085430170774097
80mg,0.15039978818924066
thymocyte,0.15037442651792599
written,0.15010275770232712
bayesian,0.14976227839117773
allow,0.14960527335581775
involved,0.14956190345332243
remains,0.1494333991741569
addition,0.1494121506305658
measures,0.14935013546662976
excluded,0.14926994887124415
screening,0.1490292349429399
dr,0.14899701022318065
vessel,0.14896864809153887
fr,0.14850563844758302
visits,0.14825440543250556
pathway,0.1478428532093455
interferon,0.14752395684048036
adaptive,0.14730158392745624
blinded,0.14726610465715811
hr,0.14724247603143936
security,0.14686010136210031
yes,0.1468377526591219
published,0.1465552891800835
hemoglobin,0.14644133468757564
performance,0.14639394781477835
reactions,0.14617097805715917
aphp,0.146127507619111
withdrawal,0.14600132050425987
absolute,0.14595953170193507
association,0.1454335931428039
bacteria,0.1453697950738124
retrospective,0.14517262114454624
biopsy,0.1451413589065299
provide,0.1446317855701622
products,0.14440880399676007
intrauterine,0.14420505021156912
laboratory,0.1438660906683329
regimens,0.14374451777454114
centres,0.14367838935244887
curative,0.14360503773796182
difference,0.143430926784437
medicine,0.14257040410421723
mmf,0.14161092417536525
sources,0.14154646752011735
carried,0.14144607417070165
chest,0.1411950319202442
cost,0.14071139005374778
decrease,0.14061462403671726
step,0.13977230712397087
lymphocyte,0.1396638887612387
pressure,0.13957641378613564
severity,0.13954565633907606
improved,0.1393832320650635
surgery,0.13936210197696175
lymphocytes,0.13932898929682364
entry,0.13905827818848424
funded,0.13887092824125621
intravenously,0.13884120211111037
cord,0.13814473552123294
male,0.1377056152005177
stopping,0.13760790328262998
schedule,0.13745923221202153
committee,0.13736200214116065
strong,0.13728418706617754
acuity,0.13715614861455364
inactive,0.1370889707517632
situation,0.13697837836577853
inclusions,0.1368562294333269
approved,0.1367375631085118
cerebral,0.13660726088562306
immunosuppressants,0.13625834700444067
2018,0.13613621800486117
fever,0.1358683301286594
w12,0.13586659498746317
interim,0.13569789654874678
sided,0.13541840326025179
diabetes,0.1353388912604824
hbv,0.13523858964829838
blindness,0.1349612969516205
forms,0.13487708043286237
combined,0.13439170714150364
enrolments,0.13438949486258606
lariboisiere,0.13423704833162348
200,0.13419928670644413
board,0.13413872764480156
rejection,0.1337282740171908
onset,0.1333279868562623
lead,0.1332933503793706
2008,0.1332159083348332
mice,0.13302946764432538
hematology,0.13296052263226812
moderate,0.13290768943936304
indication,0.1328692559849556
anaemia,0.13267789284100578
hypertension,0.13260394425489724
ctcae,0.13254295040672837
right,0.132291351914795
scope,0.13218145578690316
eligibility,0.13200447090156525
differences,0.1319964260695632
partner,0.1319703620836824
target,0.13191940146907707
measure,0.13191611041651785
biologics,0.1317086251670065
dna,0.13169600459044226
medication,0.13162914074879023
65,0.13138826909683565
outside,0.13113044607243898
potentially,0.1310281161225025
tablet,0.13093940177848584
inferior,0.13090338502784282
acts,0.13084669283804026
tel,0.13060760190809192
length,0.13049506893117657
form,0.13025809498970434
malignancy,0.13004596391525644
recipients,0.1300432268759353
characterization,0.12968312685721034
vitreous,0.1296018269519215
diseases,0.12946675026206036
occurs,0.12942454402531384
pan,0.12919324193584591
eyes,0.1291255825096031
men,0.12897768544279853
measurement,0.12893971959372816
40mg,0.12891685492228608
cause,0.12890382284111773
development,0.12888770237677422
young,0.12876988215839388
cohort,0.1286929322083234
open,0.12866817828555602
arterial,0.12840275136440998
allo,0.12808437017135255
adequate,0.12802402384662973
approximately,0.12780178792797103
european,0.127772034366414
103,0.1277611654811398
abnormal,0.12774030418124643
support,0.1276092846246915
breastfeeding,0.12741961742078287
experienced,0.1273354430333736
considering,0.12716918936176946
2017,0.1267681118514139
exploratory,0.12668904444919676
chamber,0.1265973558203064
greater,0.1264787886532346
vaccine,0.12636978660334874
w1,0.12608440929940937
large,0.1260817169634545
qol,0.12588227391162596
practical,0.1257701300281812
intermediate,0.12571494590237828
missing,0.12568320343268385
gp,0.12568320343268385
team,0.12548763084083536
multicentre,0.12547310837664616
saadoun,0.1251493928253623
grafts,0.1250296794653385
78,0.12482395430455982
detected,0.12475467160141065
procedures,0.12460457172775456
alpha,0.1242984031699314
range,0.12418854290913045
label,0.12413860354112251
parenteral,0.12391197665841404
5xuln,0.1237111455089758
device,0.12368855080231694
azathioprine,0.1232373336185554
error,0.12289409622732189
genetic,0.12287520610621332
delayed,0.12272635158979774
ventricular,0.12266931744286856
biotherapies,0.12261590248095255
unwilling,0.12176841139442963
dl,0.12160544157234894
depletion,0.12151387896743923
pneumonitis,0.12140376531195332
segment,0.12130591137433813
poorly,0.12107861952331864
model,0.12086189302003383
stratified,0.12084601259162348
david,0.12078614803338847
like,0.12077541448066369
institute,0.12076289197462715
bolus,0.12052766373518703
frequent,0.12015734054743074
examinations,0.12010041074803873
sub,0.11998360925631331
collection,0.11990395058225918
ad,0.11988240161250088
necessary,0.11985879500055178
younger,0.11985628079426393
2013,0.11937161695262491
mechanical,0.11927786476455059
ventilation,0.11927786476455059
stay,0.11927714680506887
ig,0.11918420290196481
nervous,0.11917766128820204
malignancies,0.11898260256356313
mainly,0.1189247988638276
stable,0.11886758454636882
bcva,0.11838567630111077
1mg,0.11836079954997397
certain,0.1182707518546706
practice,0.11813106835849643
vitro,0.11812279617020446
proposed,0.1180528167277625
resistance,0.11800877195462624
questionnaire,0.11800260954609772
hospitalized,0.11799089309374995
significantly,0.11790865156547417
action,0.11789072556395369
general,0.11766993387589611
corrected,0.11748730407974403
condition,0.11735613271175425
regarding,0.1171929304158632
cycles,0.11718711292080589
depression,0.11718126671770851
negatively,0.11690943239107049
hospitalizations,0.11683017829600989
properties,0.11666483565262678
tnfa,0.1164573266201247
2015,0.11643655063381093
infected,0.1163928910295318
morbidity,0.11637943120917775
plus,0.11620754247383966
diagnosed,0.11599027919092696
factor,0.11596234069477457
summary,0.11593641109517339
lower,0.11562559824325894
rationale,0.11559709182259761
physical,0.11536934877109886
coverage,0.1153484757071731
methotrexate,0.1152971183468643
circulating,0.1150979827719392
direct,0.11509183913175147
2010,0.11491571109332624
percentage,0.114818364734252
blys,0.11465764079045467
lack,0.11464858322356325
guidelines,0.11463635375585862
detect,0.11458717304989699
leakage,0.11456403513734456
sodium,0.11444063181194232
table,0.1144219032464234
live,0.11414999324703055
neutropenia,0.1137174993750496
fibrosis,0.11367907782901798
superior,0.11362885250374635
platelet,0.11354296951416719
induced,0.11336428483389892
society,0.11327075655393555
nih,0.11325192248399221
counts,0.11321853928239868
report,0.11315164879200522
solid,0.11309779188209046
immunotherapy,0.1126077332165768
vessels,0.11259593874283685
platelets,0.11249232759749286
hepatic,0.11246980241073658
neoplasia,0.11241421705988926
adherence,0.11226153234999564
illness,0.11211547673197991
obstruction,0.11199273191307241
characteristics,0.11197459839087319
rapid,0.1117675511143309
enroll,0.11174654871158664
calculated,0.11163574588255903
route,0.11162324085413056
bmt,0.11145931466925396
haze,0.11139975183014185
public,0.11136361880372214
hemolytic,0.11135097510225082
interval,0.11121776074533958
excipients,0.11078891069717794
repeated,0.11078619274473205
comparable,0.11073370563914467
sf,0.11072050582622404
director,0.1106865129094807
series,0.11045303522184147
developed,0.11039832421988885
presented,0.11038760518760496
consumption,0.11037050410823751
urine,0.11033686476406465
inhibition,0.11025423845714702
auto,0.11020291400440518
curatorship,0.11019477550189828
59,0.1098288375776574
fa,0.10976995371836377
definition,0.10959758023437259
hhv8,0.10946305803537969
weekly,0.10943339336302786
point,0.10933601248968787
tbi,0.10930414261829874
sickle,0.10917517448061437
recruiting,0.10917517448061437
unable,0.1090943969554664
recommendations,0.10880640624203389
anticipated,0.10880085293883814
bid,0.10873093087297131
candidate,0.10860091005656522
basis,0.1085540269970145
needed,0.10838564701583886
internal,0.10833855907295944
supportive,0.10830801232515755
lesion,0.10816044631223834
nicolas,0.10778735882605277
does,0.10770402200949261
consultation,0.1075556411762115
needs,0.10754186243438577
66,0.10734887829822864
remain,0.10725104725484261
testing,0.10724069581389536
microbiological,0.10721181897551844
thoracic,0.10719808148869109
150,0.10682765435146253
54,0.10674136078167998
receptor,0.10669757453168426
recurrent,0.10637571268018453
01,0.10613296748864223
vh,0.10601499551562932
comparator,0.10590243267758745
amplification,0.10583766407001699
twice,0.10573386739805192
resolved,0.10558630326271315
global,0.1055059261811003
31,0.10544288185404568
periods,0.10538868884141055
question,0.1051460510002313
normalization,0.10514080155737779
91,0.1050665985615805
optimized,0.10497699274147183
surface,0.10487259662090977
situ,0.1046941776395892
basal,0.1046941776395892
blind,0.10455132002649671
osteoporosis,0.1044312684891204
detection,0.10431009002044317
barrier,0.10423079234769518
figure,0.1041704190713488
dyslipidemia,0.10404343501445192
selected,0.10391104205680216
sclerosis,0.10383307506396758
proven,0.10375494044847001
sampling,0.10363266013624985
investigated,0.10336408626677707
37,0.10335352741407168
discontinued,0.10320708839451434
tested,0.1031763626800723
idiopathic,0.10311841009435835
dramatically,0.10309884518733922
lineage,0.10301376946517238
mismatched,0.10284595681485674
ast,0.10277435224759404
abuse,0.10275959066139555
parameters,0.10275857903379906
microbiota,0.10270654118978359
sectional,0.1026967291043409
d60,0.10243564438237006
abscess,0.1023881840094892
quantitative,0.10233554830698469
affiliation,0.10215561770549612
echocardiography,0.10211193697251751
prognostic,0.10205887513462986
conducted,0.10204535205419143
toxicities,0.10184610525173649
detecting,0.10168882336755737
conversely,0.10165272117408368
ecog,0.10162028813146093
relationship,0.10149116844715936
cd4,0.10140408586753054
determination,0.10138433685570339
csf,0.10105201721022973
chance,0.10092912102040824
historical,0.10087425059056947
progestogen,0.10026113542106485
myelodysplastic,0.09988096492786262
hypothesis,0.09986685194976863
alternative,0.09978001654912468
affiliated,0.09975331946954351
decision,0.09970008341980094
intervention,0.09967289247050663
000,0.09965424505997711
reading,0.09963366498176715
account,0.0994201046753347
w8,0.09910992486125017
w4,0.09910992486125017
experience,0.09894501057673644
parents,0.09892335069187826
aim,0.09877557093164083
400,0.09858043784170303
identified,0.09850615155033442
49,0.09842604075641127
substance,0.0983799494256936
possible,0.09828278787576938
ct,0.09822765076682469
insufficiency,0.0980384685902843
joint,0.09802326163940964
estimated,0.09798289710560087
infusions,0.09798099890462766
hematological,0.09793917160208378
acceptable,0.09784580189721781
ae,0.09771298536569467
delay,0.09756401120932423
cytokines,0.09750992041070936
grades,0.09745654865360638
adapted,0.09740770332881835
assuming,0.09712192460025133
rapidly,0.09703167749391847
malignant,0.09702487880446066
values,0.09673989840326826
pga,0.09672218447957998
centralized,0.09671605517265891
septic,0.09662832202295832
52,0.09646588136117248
uc,0.09627467922116334
bilateral,0.09617392845695381
examination,0.09615791049292607
requires,0.09611530176972224
index,0.09595364069145267
2021,0.09593378184152437
require,0.0959117177002322
neurologic,0.09590818236929322
damage,0.09587273438926829
des,0.0957825803277663
normal,0.09565354694423969
metastatic,0.09543202894799803
clonal,0.09534606959251722
prescribed,0.09530672189883252
survive,0.09521713732080445
cognitive,0.09521713732080445
ministry,0.09515124320139012
ag,0.09501828086706449
extended,0.09488570580584732
rules,0.0947509210767621
identify,0.09473477279415575
takes,0.09469157656150659
allowing,0.09469013902370389
immunodeficiency,0.09461365466047256
especially,0.09461000190028182
order,0.09443531058326808
ovulation,0.09432734114463164
dependent,0.09414998064752325
uln,0.09393982452981255
rare,0.09385325503827754
ago,0.09380422891046605
prolonged,0.09375607349147791
64,0.09372920386883131
coherence,0.09360626172443776
people,0.0935797677109196
infiltrate,0.09352833201838218
elderly,0.09342862650182757
hcv,0.09338880602958707
alloimmunization,0.09325820585455517
develop,0.09297528262166005
presenting,0.09294099914450195
antagonists,0.09285883052981392
parallel,0.09272694188640261
prevention,0.0926877516273417
500,0.09260941056945902
individual,0.09254314349376153
intensification,0.09237770000148768
schemes,0.09237770000148768
enrolment,0.09229921448780792
pro,0.09212031478033608
reasons,0.09204330393642604
cross,0.09192325781591626
apply,0.09187790787992169
composite,0.09187500031250642
justifying,0.09179825391550255
v3,0.09176066150837753
2000,0.09162857250944009
cervix,0.09151886542415849
scores,0.09148791518944573
w24,0.0913667285804108
completed,0.09122918667487409
wbc,0.09116545295682227
characterize,0.09103447929817857
squamous,0.09097037050883461
tolerated,0.0909649706894238
handle,0.09091031293436518
potassium,0.09088108241832771
infiltration,0.0906916010162614
tests,0.09066638292064534
incidences,0.09042573164494849
search,0.09032091907035292
participating,0.09022538958853679
120,0.0901680100280182
hbs,0.09013101080493774
unless,0.09007690586129732
grading,0.089979497493213
relapses,0.08988089201775734
oct,0.08978462056067155
relative,0.08977327127914436
81,0.08967555996205374
working,0.08945577042424263
literature,0.08935285536270005
discontinuation,0.08931862197205649
glomerular,0.08897138965378194
protection,0.0889633674176248
2009,0.088584712116306
production,0.08850685826815397
hemorrhagic,0.08845444768931932
blaise,0.08834370813483794
progressive,0.08830207686640336
initially,0.0882262647019571
targeted,0.08805249546696246
party,0.08800615945133963
observations,0.08795404597464274
responsible,0.08775129080892552
tapering,0.08774747885515297
5ml,0.08772750947614122
stop,0.08766186192622599
alive,0.08764511430297
meeting,0.08746999572938216
guardianship,0.0874537691196379
safe,0.08739986451265329
deficiency,0.08733472204148575
cytokine,0.08725723183597614
autoimmune,0.08723962713849415
led,0.08713695065730429
hypothesize,0.08711746497956996
diameter,0.08699818227451903
invasive,0.08699467611733609
appropriate,0.08695680182736697
average,0.08693777906615445
failed,0.08673885737855273
enzymes,0.08667617685512573
w16,0.08662033725346882
computed,0.08656481184114785
targets,0.08643855759711297
melphalan,0.08631603750426652
consortium,0.086288768711689
magic,0.086288768711689
creteil,0.08624128436810005
outpatient,0.08620512073643115
erythematosus,0.08610092744564758
permitted,0.08605111080610689
obtain,0.08595976341016577
recruitment,0.08577450630925992
log,0.08573603122816822
field,0.08573177742844909
condom,0.08568598192695054
pleural,0.08567000304172684
inform,0.08564796021713056
sterilization,0.08561777880641071
serology,0.0855249122063249
cytopenias,0.0855156185062772
undergoing,0.08550947434185471
rct,0.0854752917935432
state,0.08530195370569632
limited,0.08519135094237068
background,0.08518422425420223
switzerland,0.08484679633462297
analyzed,0.08481191606167443
reached,0.084784485653539
article,0.08475915875914014
fda,0.0847462697085901
immunological,0.08458709407217896
web,0.08456371215288959
reactivation,0.0845301638252126
27,0.08438686171403009
55,0.0843292018436936
indicated,0.08426532693740184
collect,0.08414802764811666
authorization,0.08409799514775432
effusion,0.08406946723493391
significance,0.08403780398577596
actg,0.08398131092378024
focus,0.08391640458677518
valid,0.08390916433480568
neutrophils,0.08390348867333043
consecutive,0.08388849999699742
maladies,0.08387543412769474
particular,0.0836540390815429
provides,0.08364841132429249
distinct,0.08359843678789593
bleeding,0.0835968498585366
topical,0.08353451910662031
toxic,0.0833847762976746
allowed,0.08307702337401196
regulatory,0.08306035806635235
professor,0.08282240710752918
intervals,0.08282240710752918
coli,0.08269211208786531
sustained,0.08269139820495174
mild,0.0826089192318272
d0,0.08193396773995369
fraction,0.08191999101826261
success,0.08189141604193051
neutrophil,0.08186173981799798
fusion,0.08172427483357281
numbers,0.08168014404789717
cystitis,0.0815824233368105
subcutaneous,0.08158114727425347
109,0.08145768361974594
aggravation,0.08116076021917279
gold,0.08114246074520198
gave,0.08105639487501322
cancers,0.08096404795194259
functions,0.08090507003326183
phenotypes,0.08084637503556381
volume,0.0807124885208867
suffering,0.080068352398931
various,0.0800040661281664
upper,0.07996176508615167
evaluable,0.07995240865474065
directly,0.07991963367333829
limit,0.07991211260959216
205,0.07989907118291308
pathology,0.07982497558783201
frequency,0.07980833482746828
extensively,0.07969424879017259
types,0.07957469664656996
email,0.07948863157415591
ophthalmology,0.07947651773251764
ray,0.079287130505289
nomenclature,0.07922582776642433
fm,0.07912808871175857
whichever,0.07911338643223077
standardization,0.07909565694688554
arthritis,0.07904677294723239
eventually,0.07898066072499857
10mg,0.07896715864484803
release,0.07885707608254425
pnh,0.07881325340529355
feeding,0.07881186489091685
alt,0.07873702500585439
innovative,0.07864338393583717
ebmt,0.07846389707475905
start,0.07844956943825984
conceive,0.07836122789780253
bichat,0.07834573448842079
achieve,0.07830796288430915
72,0.07820479489135959
leading,0.07819634966327776
glucocorticoids,0.07811944605268328
efficient,0.07799931831260626
induce,0.0779900649240472
du,0.07777464717710399
future,0.07771631703432652
scheme,0.07740952317685132
76,0.07727195031285095
nk,0.07722771910859552
mutation,0.0771644496047187
deletions,0.0771644496047187
rearrangements,0.0771644496047187
generation,0.0771644496047187
confirm,0.07714453280172229
residual,0.07707798793752788
usually,0.07703974840510688
30ml,0.07698340296351576
dsmb,0.07690416180126823
murine,0.07683852057062443
mm,0.0767388690175427
maintenance,0.07664711913009528
criterion,0.07658226087487294
express,0.0764954387897076
sole,0.07647375389148234
taking,0.07642074376603301
monotherapy,0.07639596804856898
reproductive,0.0762812433487013
symptomatic,0.07618134191370132
thymoglobulin,0.07612844439028314
specifically,0.07610909553248174
copy,0.07610464771232162
consistent,0.07600963860750527
recherche,0.07600631754472228
la,0.07599502476532338
child,0.07599316663961343
tissues,0.07597730211494069
rbc,0.07594213478646197
anxiety,0.07590597115479308
capillary,0.07590597115479308
nyha,0.07590418256098178
information,0.07584909644347956
million,0.07581313763089076
exposure,0.07575887649428373
applicable,0.07566647626344719
developing,0.07561855806645515
favorable,0.07538517757745931
transient,0.07522098501092286
multicentric,0.0751220376102255
chosen,0.07511481893373667
profiles,0.07511109415452351
immunogenicity,0.07501324675990692
transdermal,0.07499665228979358
define,0.07497523163503196
difficult,0.07484384485331684
organs,0.07477967082174072
targeting,0.07464647050283885
compounds,0.0746302605180293
assessing,0.07459515987153512
systematically,0.07445463943114738
affect,0.07436295194723261
understanding,0.07428742675556307
containing,0.07410247433553238
cyclosporine,0.07405203772181727
shock,0.07397949724084776
simple,0.07397949724084776
lymphopenia,0.0739647172610581
liability,0.073951593124405
excessive,0.07391726826432052
prescription,0.07390411571261034
rt,0.07386170240648413
salpetriere,0.07356601851052869
pitie,0.07356601851052869
complication,0.0734086397934276
tablets,0.0732618978979889
screened,0.0732618978979889
humans,0.07304864120597332
visceral,0.0729780498223129
yielded,0.07289699307489653
rest,0.07278344965374292
ius,0.07270190790955983
opportunity,0.07268045909474415
92,0.07266465424627512
prednisolone,0.07256986878447132
strategies,0.07253434271738188
77,0.07235520761165053
immunosuppressed,0.07228661059361696
august,0.07223290662039407
alat,0.07223141497187331
discretion,0.07219768462322869
determine,0.07215121185357332
na,0.07212467456593828
preceded,0.07207981615617452
intent,0.07192108549453512
specified,0.07177247510767232
microns,0.07158254543889189
debilitating,0.07145133093526271
choice,0.07140869046457485
healthy,0.07136890035831112
chru,0.07136824747940032
270,0.07136504565484351
ulcerated,0.07134510156065545
sufficient,0.07133739609873672
expert,0.07122276060022636
bacterial,0.0711601475496899
pao2,0.07110587743853246
matching,0.07110587743853246
mmol,0.07110587743853246
relapsing,0.07109648878327447
digestive,0.07088566820941586
markers,0.07086239967200768
recorded,0.07077827946392906
simultaneous,0.0707004750901668
collaboration,0.07067311051262165
suggest,0.07065132977496585
screen,0.07052753166544683
73m2,0.07046232417939269
important,0.07045379978948038
birth,0.07039452293367299
cmu,0.07037241668298508
universal,0.07037241668298508
authority,0.07035157665657588
concerned,0.07035157665657588
meet,0.0702428890152235
88,0.07022260767090338
iud,0.07008725462828873
2011,0.06997561830559476
phenotyping,0.06997454152524546
02,0.06992892584132676
dependence,0.06978161824317461
mixed,0.06975022127475294
truly,0.06973322345018414
recovered,0.06973322345018414
beginning,0.06973322345018414
scan,0.06967586200053288
haematopoietic,0.06956064885229851
efs,0.06953407410605533
complement,0.06942384319943067
arrest,0.06940902730325962
confidence,0.06933304778111075
recognition,0.0692867034655887
maintain,0.0692867034655887
apparent,0.0692867034655887
rna,0.06925627500613077
tutorship,0.06920646144706105
cataract,0.06916514745399607
162,0.06911533352945923
recommendation,0.06908978620460954
usa,0.06907448748402127
permanent,0.06905906821068254
physician,0.06899528669550266
healthcare,0.06898567105096065
transaminases,0.06897919578743053
recovery,0.0689308096701757
enzyme,0.06873444414191425
800,0.06870207266913479
evaluating,0.06854623402784597
knowledge,0.06845067106890534
minimum,0.06836102839037932
kroger,0.06833100252445387
ferritin,0.06829166465641022
expecting,0.06822600953238776
chemotherapies,0.06822600953238776
borr,0.06822600953238776
projected,0.06822600953238776
hypotension,0.0682236244248888
cream,0.06798901122372308
blocks,0.06794719230581339
network,0.0678986077273228
comply,0.0678617630076622
hcg,0.06778253804231915
concomitant,0.06777539687512002
interfere,0.06774803268445453
41,0.06774099870817256
died,0.06770382974718843
binary,0.0676785045594109
requirements,0.06752181848390833
preferred,0.06749806415503433
father,0.06749592148557675
ejection,0.06744802148631873
eltrombopag,0.067376348147582
nei,0.06713679196566676
frequently,0.0671222449031382
bearing,0.06702017261336579
thrombocytopenia,0.06700813102036347
isolated,0.0669713422769046
variety,0.06687940562610732
antithymocyte,0.06684845773477936
32,0.06682274768820819
behcet,0.0667675468778037
june,0.06672064801598962
successful,0.06669366282289979
cd34,0.06651356373189374
mobilized,0.06651356373189374
confirming,0.06647627011923307
mesenchymal,0.06611818328950568
reduces,0.0659982130347816
improves,0.0659982130347816
superiority,0.06596635504679434
involving,0.06588316589112024
consider,0.0658088829045719
surveillance,0.0655787599323333
willing,0.06550041364257805
constipation,0.06548168157575526
suggesting,0.0653748789787919
2mg,0.06526036901138418
1000,0.06525956201087599
dosing,0.06520588575917183
addressing,0.06517028872583362
novo,0.06514957390440632
registered,0.06514453630437608
sequence,0.06510775498649662
appears,0.06504362271043321
rank,0.06501097828517974
section,0.06493451591408031
service,0.06484156342860517
regression,0.06481201442886445
immunosuppressant,0.06480724311584223
particularly,0.06475209964743223
mol,0.06473469580111267
htlv,0.06465198382243145
gives,0.06464328442492359
oxygen,0.06464080557758728
75,0.06461595541211998
standardized,0.06459517311806437
unique,0.06448950801675976
longer,0.06434718868219354
myeloma,0.06433656614642522
earlier,0.06426057354594426
repair,0.06423560634016025
harm,0.06408128577052673
fewer,0.06404100106909205
cs,0.06399786209941918
swelling,0.06390865971128207
optical,0.06383134868189003
cycle,0.06381858673843062
binding,0.06373719357735178
62,0.06368102720610286
reaching,0.06366166984186251
monetary,0.06366166984186251
investigation,0.06366166984186251
34,0.06364697089804518
gastrointestinal,0.06361486383776808
lifestyle,0.06356396149819772
nephropathy,0.06356255282484606
hypothyroidism,0.06354468942872188
fulfilling,0.06353952084527864
extensive,0.06338847540314103
instability,0.0633777281169281
syndromes,0.06332765689394365
anticipate,0.06332349915078958
teams,0.06328268454403377
allergic,0.06324212895200294
formula,0.06319938978448389
propose,0.06319893788725729
affected,0.06318811981921948
independence,0.06317991654024879
nephritis,0.06302971044794102
chu,0.06302364908071593
impaired,0.06293600398003968
registry,0.06292652304600585
taken,0.06285077756755897
linked,0.06284926055948495
person,0.06283963928812032
monthly,0.06281689187350957
rares,0.06277654853900108
systemiques,0.06277654853900108
thanks,0.06276757771644874
largely,0.06276686212532512
caused,0.06276384951777705
asat,0.06272339081321836
tubal,0.0626059546234785
collective,0.06259340660756163
american,0.06258566732027286
toulouse,0.0625088165673444
shall,0.0622293777124061
nb,0.06214844102477616
chills,0.062111221101200376
avoid,0.062007628161241696
reactive,0.06200334566571319
behalf,0.06195235958153472
plasmapheresis,0.06193790589123707
injury,0.061906254159450676
aimed,0.061842495868918754
ctc,0.061751247238211175
directed,0.06173884683974564
little,0.06168900320325545
informative,0.061587935416466455
conclusion,0.06156180732163956
decades,0.06155776493857486
documented,0.06153608470288602
sequential,0.061415488206809074
98,0.06135203376231363
modalities,0.061344571554994266
eu,0.06123381378671416
continue,0.0611911143104763
goal,0.06107103224689968
review,0.060840985553175506
intolerance,0.060755807580375375
randomizations,0.06055383351208348
half,0.060548839143026806
lives,0.060548839143026806
57,0.06041928104929094
225,0.06038144598731358
1080,0.06038144598731358
inference,0.060317819949179105
loss,0.06022245974962786
transmission,0.060222000723548226
deaths,0.060222000723548226
st,0.06008688410317414
immunophenotyping,0.06008688410317414
components,0.060038579412969195
filtration,0.06002745058989417
divided,0.059928140397131964
chromosome,0.059928140397131964
tolerability,0.05977067882968279
encouraging,0.05947996865915804
exceed,0.059461190988222626
project,0.05926498660768572
headache,0.059150820735265786
starch,0.05907839732180893
publication,0.05897897411269005
states,0.058965208038533876
2n,0.05888924617067064
replete,0.05888924617067064
contraindication,0.058886684474011734
inhibit,0.05882971039695594
intercourse,0.05878747250171231
cgy,0.058741243262244225
willingness,0.05872673951103658
validated,0.05871589017465975
regulation,0.05871323177394919
explained,0.05867242480142018
systematic,0.05863480185634698
difficulty,0.05859994907756294
aplasia,0.05859994907756294
validate,0.058582423543602574
cm,0.05851862125124515
tube,0.05851862125124515
pd1,0.05849737785353179
randomisation,0.05844151285816798
mucocutaneous,0.05823872798684053
occur,0.05822137701467755
demyelinating,0.05821935261258835
recruited,0.05813455233566336
correlate,0.05813455233566336
issues,0.0581227557628311
mdrd,0.058068841460743315
progressing,0.058068841460743315
gamma,0.058056762836741334
points,0.057992402387824854
deep,0.057984889210688007
called,0.05798481218638729
newly,0.05798481218638729
globuline,0.05796288477540098
pbsc,0.05796288477540098
anaphylactic,0.05793386495800141
accordance,0.05784327030952093
attenuated,0.05783588029909108
determined,0.05772303560276844
dexamethasone,0.05767502681003896
reviewed,0.05762486612058796
decade,0.05755386247996244
cardiovascular,0.057506440966442016
white,0.05746206758869203
hg,0.057361971645068725
formal,0.057361971645068725
recurrence,0.057360247936884184
preexisting,0.05734718355305756
leukoencephalopathy,0.05732882039522733
multifocal,0.05732882039522733
c4,0.05732882039522733
referral,0.057245182559407935
affiliations,0.057234478921203334
marked,0.0569525766934032
man,0.05688096518152197
50ml,0.05685653391097397
europe,0.05680401841428115
models,0.05672377311734136
quick,0.0567178013767137
initiated,0.05664537805091271
roughly,0.05664537805091271
code,0.05661056653191821
controls,0.05656167439106019
proliferation,0.05646718177791682
final,0.05646037800045167
hope,0.05636999029712081
analyse,0.05636999029712081
rue,0.05636999029712081
successively,0.05636999029712081
cough,0.05630748472787366
47,0.0562151552647335
proved,0.056208748724576416
film,0.056208748724576416
water,0.05613076617499782
adding,0.05609152816411034
exchange,0.0560832261468142
implemented,0.05594906323473032
therapeutically,0.05593944288987045
tacrolimus,0.05593944288987045
admission,0.055881864476262956
rheumatoid,0.055869632651015994
understand,0.05578851130637942
releasing,0.05570984198688935
intravaginal,0.05570984198688935
365,0.05570605836272756
resonance,0.055687266993498255
magnetic,0.055687266993498255
logrank,0.055683283227345975
220,0.055679183931928375
slow,0.05566709612926693
sequencing,0.05566217549469411
load,0.05566217549469411
lebbe,0.05548513597658804
cochin,0.05548513597658804
celeste,0.05548513597658804
did,0.05545136695012926
rubi,0.05542240243850566
times,0.05538588181091334
regis,0.05532726126961912
peffault,0.05532726126961912
trm,0.0553233701197788
75010,0.05525409357065439
raising,0.0552465811177736
chorioretinal,0.0552465811177736
equal,0.05522452155596054
world,0.055121326565197845
sustainable,0.055118557423580294
firm,0.05507149630204393
cmv,0.05505476294692889
classical,0.0549449202995789
commonly,0.0549165769502446
confounders,0.05490860847474131
affecting,0.054806817841964645
inhibitors,0.05479728332346882
category,0.054783148520613764
uni,0.05474879218408058
conditions,0.05473117925646636
63,0.05472527732338605
evaluations,0.05467889680651472
38,0.05463025617655635
lowest,0.05461957317655998
vaccines,0.05453035890733608
showing,0.054498069523668216
involves,0.054449458754197155
adaptation,0.05442163254894995
mediated,0.05434168691583673
assumption,0.05434059617501521
56,0.054322869037996664
respect,0.05428230434268795
estimation,0.05427694567743261
molecules,0.05427694567743261
immediate,0.054244293183267456
capacity,0.05417283009780184
participated,0.05404397544647467
failures,0.05390721257926395
44,0.05388426916874996
glaucoma,0.05378905533318781
ability,0.05375178479836151
29,0.05374711294393057
feasibility,0.053689749692775735
fixed,0.05366892760401255
04,0.053581080293433905
responding,0.05348166103899096
1st,0.05333110663189004
authors,0.05320063371430763
respond,0.05308006147636561
lancet,0.05305712192375605
effectiveness,0.05303172749417939
im,0.05301389996018845
decided,0.052972081042278754
categorical,0.052972081042278754
sante,0.05291214465083331
applies,0.05289262610406592
mucositis,0.05287820309893607
departments,0.05280898826824652
options,0.052747511809565814
relation,0.0527469606456634
dyspnea,0.05268535733055382
anc,0.05262381011165586
foam,0.052570400778688894
studied,0.05256353928317717
infarction,0.05254106059385576
myocardial,0.05254106059385576
58,0.05250288614684898
contraindications,0.05250288614684898
spontaneous,0.052420068725441867
questionnaires,0.05232149519568197
autoimmunes,0.05224876852416508
immunology,0.05224876852416508
flexibility,0.052182567304020405
offers,0.052182567304020405
simplicity,0.052182567304020405
pt,0.05190650493948816
hospitalier,0.051812592054028765
exact,0.05173422138195974
burdens,0.05169824546261676
paroxysmal,0.05169617918855033
hematologic,0.051628095641282665
artery,0.05161300833225358
represents,0.05159536939159484
disappointing,0.051547024980721376
flare,0.05154568910030202
alloreactive,0.05149447440603901
lymphoid,0.051438572680000134
herpes,0.05135758497820683
provided,0.05135526416822185
concept,0.051328948750552654
culture,0.051328948750552654
represent,0.051328948750552654
alcohol,0.051272708536823294
inadequate,0.05121449552085131
fluorescein,0.05104210799608141
uveitic,0.05104210799608141
extra,0.05102661330786907
brain,0.05100110389465137
arrhythmia,0.05100110389465137
osteonecrosis,0.050987315217302064
reason,0.05092204344785036
redness,0.05088262067515965
suggestive,0.05084421849979603
grim,0.05084353196035832
hemoglobinuria,0.05084353196035832
nocturnal,0.05084353196035832
prophylactic,0.05082760522426712
providing,0.05060022043649377
implementation,0.05043678968235182
united,0.05041333396916165
inserm,0.050386287003020475
luznik,0.05034596754464121
sas,0.05034596754464121
avenue,0.05028772772208584
da,0.05004653012869538
explore,0.049974256469571335
1500,0.049954502543169584
85,0.04993804011810811
06,0.04993151177067627
clinique,0.049920414535429405
longitudinal,0.04991776404839879
width,0.04991776404839879
gfr,0.0497766016500214
safely,0.049765855881376074
successfully,0.049765855881376074
march,0.049765855881376074
vaginal,0.049654655996236974
ring,0.049654655996236974
diaphragm,0.049654655996236974
favourable,0.049637785811506394
w10,0.04958718282028919
w6,0.04958718282028919
generally,0.049566925747404136
relapsed,0.04953598349365638
favor,0.04953598349365638
bortezomib,0.04953598349365638
version,0.049467255125258076
ensure,0.049455154597985884
latour,0.04930146051639396
seropositivity,0.04930146051639396
heterosexual,0.0491682614930465
market,0.049157530427711
corresponding,0.0491558333477579
calcineurin,0.048823087591821746
likely,0.048784455668912166
colitis,0.04868764356721654
csa,0.04868661335815055
ongoing,0.04867885842355858
college,0.04863359136040088
consistently,0.048625254500333163
haematological,0.048552807406919696
note,0.04851060404911046
positivity,0.04844841944509354
percent,0.04841859246289036
aom,0.04841815956786562
quantiferon,0.048251551846127706
lateral,0.048251551846127706
postero,0.048251551846127706
aggressive,0.04824710306998013
burden,0.048245772043095714
acting,0.04818617963126241
gut,0.04816411084899521
ulcerations,0.04816411084899521
farge,0.04813733961058167
gov,0.04809433763747631
thrombopenia,0.04796479633438622
approval,0.04789198125950684
antiviral,0.04786982467282709
complex,0.0477924664529141
challenge,0.0477924664529141
naive,0.04778079534470938
match,0.04766431186752188
worldwide,0.04766431186752188
hbsag,0.04756476500356789
vasectomy,0.04753125753921118
publications,0.04744598531383401
pi,0.047432590698052654
146,0.047432590698052654
thickness,0.04736840691703162
exists,0.04728714979334695
london,0.04724873406663171
correctly,0.04716367057231582
necrosis,0.04706757023771466
immunity,0.04700339013131409
opportunistic,0.04700339013131409
compatible,0.04692153708074022
terminal,0.04692153708074022
30mg,0.04692153708074022
anaphylaxis,0.046738358752098474
marie,0.04673683014984448
suppressing,0.04670756241212504
alterations,0.04665824944511093
opinion,0.04658683311854957
epidemiology,0.046429246477896875
43,0.04640499114183173
rarely,0.0463776251401026
remaining,0.046339845940696206
designed,0.04633472191967179
empirical,0.0462516295198399
decreasing,0.04623998142037315
muscle,0.04623998142037315
condoms,0.046142457165676116
crohn,0.04606015739016804
fistula,0.04606015739016804
immunologic,0.04603850014736825
sperm,0.04603850014736825
actual,0.04600955085507231
hazard,0.046006620909198936
follows,0.0459895117574408
occurred,0.045932554533934425
2022,0.045873581412563105
agree,0.04580566138518478
79,0.04566224333663638
compensation,0.045646309858445894
documents,0.045646309858445894
appendices,0.045646309858445894
collaborator,0.045646309858445894
sealed,0.045646309858445894
envelope,0.045646309858445894
list,0.045646309858445894
notes,0.045646309858445894
undergo,0.045499927204611795
achieves,0.0454429841381951
ac,0.04541729525103079
favour,0.04537927590263485
gj,0.04534426807331018
special,0.04533155323028418
locally,0.04528973431237448
saes,0.04528973431237448
rabbit,0.045284611357255505
subset,0.04528248527407494
noninfectious,0.04520688837786495
ifn,0.04518319633451978
sud,0.045112694794268396
groupe,0.045112694794268396
irrespective,0.04508708709380031
bio,0.04506084970502148
checked,0.044948490489401166
encephalitis,0.04494499203624733
existing,0.04490865224078027
complementary,0.044808955094055886
vellefaux,0.044805599385349684
claude,0.044805599385349684
local,0.04480266920475261
preventing,0.04478838246600351
clinicaltrials,0.044751668276167576
mechanisms,0.0446228938226814
starting,0.044558656224583396
dlco,0.04453239351667357
underwent,0.0445025376321589
patterns,0.04449081384036126
mentioned,0.04445293313632903
119,0.04443828619869324
transplants,0.04443765689294696
industrial,0.044379452138211664
beneficial,0.04432379060175627
notably,0.044321794217774935
d14,0.044212671159634426
reach,0.044135990672058784
sera,0.04413502583944056
cytotoxicity,0.044130377422276365
devastating,0.04398170650957023
cystoid,0.04398170650957023
set,0.0439504165389292
ss,0.04392370801142707
fvc,0.043900401725121385
sf36,0.0437873478450508
altered,0.04373181098761926
crp,0.04370749637893729
modified,0.04370114531942025
attributed,0.04365531650308766
principle,0.04360548087647203
quantification,0.04360548087647203
acr,0.043597575725597026
leflunomide,0.04358809143934966
select,0.04358809143934966
scheduled,0.04354350998771051
pharmacokinetic,0.04354350998771051
proof,0.04352177721661951
applied,0.04340344476629553
activated,0.043399216353195366
activation,0.043399216353195366
subsequent,0.04317473586329854
biologically,0.04310001080621095
spectrum,0.04308460739019687
compliance,0.04306168198322796
concerning,0.04306168198322796
immunoglobulin,0.04306168198322796
england,0.04306168198322796
preclude,0.04305946293720585
2001,0.04302885415341073
53,0.04301527058903102
vivo,0.042999882643627925
modifying,0.0429643995916493
characteristic,0.04292130193889438
molecule,0.04292130193889438
accounting,0.042858581336187425
garcia,0.042858581336187425
hypotheses,0.04283049478100906
help,0.04282996081375873
paracetamol,0.04273799271779782
kinetic,0.042701708120238754
modification,0.04266325388402882
administrated,0.04266325388402882
epi,0.04242402976190582
ckd,0.04242402976190582
vital,0.04241521911975646
finger,0.04238686038153409
conduct,0.04238686038153409
contra,0.04238686038153409
cedex,0.04238686038153409
investigations,0.04238686038153409
methylprednisolone,0.0423617889423276
comparatively,0.0423617889423276
withdrawn,0.0423617889423276
proportions,0.04226157002032452
courses,0.042147476711537936
resting,0.04210604042425013
dominique,0.04210604042425013
fai2r,0.04210604042425013
characterized,0.04209690072821473
address,0.042076562672018085
proportional,0.042001369145956834
www,0.04194401935778609
findings,0.04194336120003453
thoroughly,0.041907626626538755
rule,0.04187431925478091
reappearance,0.0418636613719493
precludes,0.04184649754757016
gray,0.04177041539820408
software,0.04163720398207899
plays,0.041538329912757785
advance,0.04142842959496344
overlap,0.04136485861441174
histologically,0.04123704850299193
codified,0.04123704850299193
implies,0.04123704850299193
lymphedema,0.04123704850299193
mellitus,0.04123704850299193
psoriasis,0.04123704850299193
signing,0.04123704850299193
vitiligo,0.04123704850299193
foxp3,0.04123704850299193
merkel,0.04123704850299193
washout,0.04123704850299193
cooperation,0.04123704850299193
exceptions,0.04123704850299193
thyroxine,0.04123704850299193
sgpt,0.04123704850299193
undergone,0.04123704850299193
pituitary,0.04123704850299193
evasion,0.04123704850299193
axis,0.04123704850299193
bacillus,0.04123704850299193
adrenal,0.04123704850299193
physiologic,0.04123704850299193
correlative,0.04123704850299193
insulin,0.04123704850299193
sgot,0.04123704850299193
occlusion,0.04123253720799906
act,0.04123253720799906
vasectomised,0.04123253720799906
implantable,0.04123253720799906
successive,0.041179617860345435
process,0.04109614409052245
throat,0.041064096700462
nose,0.041064096700462
associating,0.040858845495235746
cox,0.04085549922666279
family,0.04081310548074752
techniques,0.04077174392524105
growth,0.04065801293254981
randomised,0.040642006017924975
lee,0.040642006017924975
organization,0.04062866271233174
preliminary,0.04056451950598485
gammaglobulin,0.040504626322479746
correlated,0.040504626322479746
igg,0.040504626322479746
131,0.04043876046077221
fleming,0.04039694154286251
obrien,0.04039694154286251
finally,0.04039694154286251
demets,0.04039694154286251
futility,0.04039694154286251
lan,0.04039694154286251
far,0.04034201495946617
108,0.04034201495946617
occlusive,0.040310507767252236
drop,0.04029152729007079
inefficacy,0.04028264815557295
erythema,0.04028264815557295
law,0.04026868884934254
wide,0.04018832924621492
fact,0.04018603890731329
5n,0.04018498518949002
observation,0.04018498518949002
bodaghi,0.04005092698610371
bahram,0.04005092698610371
participant,0.04003672113564101
unacceptable,0.03993308020490375
appearance,0.03986704526498042
61,0.03980989176575123
disodium,0.039789634081713515
chi,0.039789634081713515
hb,0.03964960333444356
medac,0.039548881357336516
robin,0.039548881357336516
shimoni,0.039548881357336516
castagna,0.039548881357336516
ctae,0.03953551002565698
03,0.03939514618650723
md,0.039327280716922056
percutaneous,0.03930716354709646
judgment,0.03930716354709646
priming,0.039264338880483925
drci,0.03916678000987636
les,0.03916678000987636
university,0.03916678000987636
optimize,0.03911284890069426
improvements,0.03909693156077889
larger,0.03905155940205889
v5,0.03905155940205889
features,0.03898060301305131
amenable,0.03882474409776768
packed,0.03882474409776768
cat,0.03878315434083072
rescue,0.03874302672400881
beta,0.03857230976696634
cytogenetic,0.038489902564745423
angiography,0.038473222432604814
flu,0.03845949233872359
fully,0.038427552490535734
yellow,0.038427552490535734
clinic,0.03826023033885164
author,0.03815631928080222
proposes,0.03799946408173091
comparisons,0.03798442340403579
patch,0.037970460108769755
sponge,0.037970460108769755
ligation,0.037970460108769755
panel,0.03795914903377175
noted,0.03793867926203455
effector,0.037917088016459204
computation,0.03790025647586244
consisted,0.03776023995960791
vegf,0.03766984613308872
increasing,0.03760200586054263
psl,0.037531979580945625
0142178088,0.037531979580945625
proteins,0.03745881383868656
smpc,0.037249708100439004
calculation,0.037249708100439004
functional,0.03714343667696701
supplementary,0.03714343667696701
ideal,0.037121897989019194
tubes,0.03702472236712647
recombinant,0.03700557012482392
occurring,0.03689691225570666
assay,0.03689680227306162
implants,0.036672767866904155
cap,0.036672767866904155
validity,0.036672767866904155
suggested,0.0366663305370384
colonic,0.03663094894899445
novel,0.03663094894899445
pathogenesis,0.03655081161100289
urgent,0.03646423364385234
enhance,0.03646423364385234
relevant,0.03646423364385234
mass,0.03639172482687146
phosphatase,0.03639172482687146
addressed,0.03639172482687146
gt,0.03639172482687146
alkaline,0.03639172482687146
transfused,0.036308021167018936
microg,0.036308021167018936
100mg,0.036192468421170326
hospitals,0.036192468421170326
physicians,0.036102658570370566
gained,0.0360747412379186
105,0.0360747412379186
uf,0.0360747412379186
hormone,0.03599556522748373
refraining,0.03599556522748373
york,0.03599556522748373
reliability,0.03599556522748373
masquerade,0.03599556522748373
ctfg,0.03599556522748373
estrogen,0.03599556522748373
entire,0.03599556522748373
guidance,0.03599556522748373
concluded,0.03594106598666415
375,0.0359023537131487
comprehensive,0.035861163257806236
aspiration,0.035861163257806236
epstein,0.035861163257806236
indications,0.03585648379174078
dropping,0.03584645386441153
ensuring,0.03570787788295832
reporting,0.035517087190335334
pivotal,0.035449048122967085
era,0.03512104150952373
suppression,0.035089074259977884
unaffected,0.035089074259977884
dividing,0.035089074259977884
leaving,0.035089074259977884
cni,0.035089074259977884
gammaglobulines,0.035089074259977884
generated,0.035089074259977884
536,0.03497971966408055
mouse,0.03475223632398049
meta,0.03471142315477362
supporting,0.034710417406070795
typically,0.03470451365162981
predictive,0.03470451365162981
revealed,0.03470451365162981
probably,0.03470451365162981
combine,0.03464337374479855
bm,0.03462671374621827
excised,0.03461436977183739
glucocorticoid,0.03461436977183739
properly,0.03461436977183739
myocarditis,0.03461436977183739
interquartile,0.03460155482688885
percentages,0.03460155482688885
3mg,0.0345725508539277
authorized,0.03452953410534127
signaling,0.034527474133523736
latent,0.034523146810787844
igra,0.034523146810787844
spot,0.034523146810787844
seen,0.03451785116703633
le,0.03439032668693417
causes,0.034364402849312
benchmark,0.03426251657551436
nowadays,0.0342265362971689
neuro,0.0342265362971689
warranted,0.0342265362971689
measurable,0.034176909821903786
court,0.034176909821903786
posttransplantation,0.034176909821903786
07,0.034111116277338704
attractive,0.03402329245339136
87,0.03357649580019557
importance,0.033536405395044065
critical,0.033536405395044065
cy,0.03345405722541702
rm,0.03345405722541702
haematol,0.03342543670298833
base,0.03342543670298833
accepted,0.03342543670298833
itching,0.03334361397852237
azoospermia,0.03334361397852237
documentation,0.03334361397852237
spending,0.03330560281910186
interview,0.03327485861206209
74,0.03322952066973578
concurrent,0.03302026021572736
contact,0.03302026021572736
prostate,0.03302026021572736
member,0.03299421559441401
nerve,0.0329288440553033
ema,0.0328870251373936
reports,0.032803321477541086
crucial,0.032602159500317966
00,0.0324013316298787
beelen,0.03236093256482856
modulate,0.0323419850325907
attacks,0.03214739551041424
http,0.032130045566575796
crohns,0.03207702747458132
uveites,0.03191567434094501
answer,0.03178742164742504
alkylating,0.031466159421987286
monocular,0.031466159421987286
8g,0.031466159421987286
chlorambucil,0.031466159421987286
propensity,0.031212110237506807
naturally,0.031212110237506807
ms,0.031200091657763496
details,0.03111213749063548
br,0.030968370488294268
fast,0.030968370488294268
med,0.030968370488294268
nguyen,0.030968370488294268
limiting,0.030968370488294268
inactivity,0.030906426238581995
controlling,0.030906426238581995
indicate,0.030864607320672297
inhibits,0.030864607320672297
blocking,0.030864607320672297
interactions,0.030840117794774295
essentially,0.030840117794774295
covariate,0.030840117794774295
carefully,0.030840117794774295
obviously,0.030840117794774295
realization,0.030840117794774295
gvh,0.030840117794774295
increasingly,0.03078407742726926
natural,0.03074079394931622
hand,0.030486444375683965
d45,0.030486444375683965
just,0.030486444375683965
forced,0.030047633352475712
myelodysplasia,0.03004344205158707
necessitating,0.03004344205158707
produced,0.03004344205158707
vary,0.03004344205158707
monocentric,0.03004344205158707
sign,0.03004344205158707
congestive,0.03004344205158707
way,0.03004344205158707
1h,0.03004344205158707
3rd,0.03004344205158707
optional,0.03004344205158707
degree,0.03004344205158707
similarly,0.03004344205158707
pulse,0.03004344205158707
benign,0.03004344205158707
36v2,0.03004344205158707
2nd,0.03004344205158707
112,0.02998410840688775
medecine,0.02998410840688775
dc,0.02998410840688775
interne,0.02998410840688775
grant,0.02987524582770581
https,0.02987524582770581
org,0.02987524582770581
481,0.02987524582770581
regional,0.029846241854744656
7mg,0.029846241854744656
plan,0.029846241854744656
39,0.029699099022682564
associations,0.02968346818859787
urgently,0.02968346818859787
kaplan,0.029421940237524195
meier,0.029421940237524195
karyotype,0.029421940237524195
se,0.029356615886974594
presentation,0.02919770951278885
league,0.02919770951278885
rheumatism,0.02919770951278885
eular,0.02919770951278885
survey,0.02919770951278885
001,0.02890510970175462
expansion,0.02882841279900787
appear,0.028720937137648957
104,0.028680123968442092
immediately,0.028680123968442092
retrospectively,0.02859541455988674
boundaries,0.028506730694969354
damages,0.028305283265959106
1121,0.028305283265959106
autoinflammatoires,0.02816071613821056
juvenile,0.02816071613821056
ulceration,0.02814968174707696
randomly,0.02805342510478774
assigned,0.02805342510478774
mfi,0.027969721444935224
diphenhydramine,0.027969721444935224
engrafted,0.027969721444935224
uk,0.027969721444935224
john,0.027969721444935224
historic,0.027969721444935224
cgvhd,0.027969721444935224
hopkins,0.027969721444935224
nationwide,0.027969721444935224
kings,0.027969721444935224
morphologic,0.027969721444935224
neutrophiles,0.027969721444935224
pyretic,0.027969721444935224
150mg,0.027969721444935224
coronary,0.027969721444935224
haplotype,0.027969721444935224
allograft,0.027969721444935224
cytolysis,0.027969721444935224
antihistaminic,0.027969721444935224
d35,0.027969721444935224
geno,0.027969721444935224
impairment,0.027910457624953963
conjugate,0.027910457624953963
covering,0.027869704307976886
april,0.027869704307976886
162mg,0.02771120121925283
nature,0.02771120121925283
immunosuppressors,0.02771120121925283
selecting,0.02771120121925283
contrasting,0.02771120121925283
guarantees,0.02771120121925283
ophthalmologic,0.02771120121925283
contrast,0.02770741054802895
consensus,0.027595145563855394
blockers,0.02718479176313112
zero,0.02718479176313112
sustain,0.02718479176313112
collected,0.027119116991810008
89,0.027043034842443924
revised,0.026963153772303215
nathalie,0.026963153772303215
interaction,0.026310685846259164
mechanism,0.026310685846259164
jh,0.026266108432909066
clin,0.026266108432909066
immunol,0.026266108432909066
mj,0.026266108432909066
martin,0.026237487910480372
randomize,0.026237487910480372
produce,0.026229150204153298
icbd,0.026091283652010203
reactants,0.026091283652010203
depends,0.026091283652010203
75013,0.026091283652010203
colchicine,0.026091283652010203
paraclinical,0.026091283652010203
advocated,0.026091283652010203
antiinflammatory,0.026091283652010203
lhopital,0.026091283652010203
nonsteroidal,0.026091283652010203
guided,0.026091283652010203
etanercept,0.026091283652010203
irreversible,0.026091283652010203
250,0.026045728288249786
surgical,0.026045728288249786
agvhd,0.025812802842727457
sfgm,0.025812802842727457
tc,0.025812802842727457
posttransplant,0.025812802842727457
jean,0.02580650416612679
ischemic,0.02580650416612679
begin,0.025684992731307647
identifying,0.025684992731307647
cibmtr,0.025172983772320606
sakellari,0.025172983772320606
nc,0.025172983772320606
blast,0.025172983772320606
increases,0.025143979799359454
h2,0.025080838304303948
86,0.025080838304303948
g1,0.025080838304303948
theoretical,0.025080838304303948
balance,0.025080838304303948
indirect,0.025080838304303948
example,0.025080838304303948
exceptionally,0.024793591410144596
mouth,0.02466806883238238
familial,0.024016334166144182
guarantee,0.024016334166144182
analyze,0.024016334166144182
essential,0.024016334166144182
130,0.024016334166144182
judgement,0.024016334166144182
updated,0.02398733019318303
gadolinium,0.02398733019318303
disappearance,0.02398733019318303
83,0.02398733019318303
enhancement,0.02398733019318303
111,0.023952809220556218
zhou,0.023804468639584152
expect,0.023804468639584152
unknown,0.023804468639584152
explored,0.023804468639584152
analyzing,0.023720764979731634
proposing,0.023499503630374608
recommend,0.023499503630374608
direction,0.022823154929222947
71,0.022823154929222947
voluntary,0.022823154929222947
versions,0.022823154929222947
decisions,0.022823154929222947
staff,0.022823154929222947
covers,0.022823154929222947
ethics,0.022823154929222947
ctis,0.022823154929222947
insure,0.022823154929222947
correspondence,0.022823154929222947
council,0.022823154929222947
linnovation,0.022823154929222947
biomedic,0.022823154929222947
archiving,0.022823154929222947
archived,0.022823154929222947
n536,0.022823154929222947
beneficiaries,0.022823154929222947
binders,0.022823154929222947
fault,0.022823154929222947
sponsors,0.022823154929222947
submit,0.022823154929222947
policy,0.022823154929222947
prove,0.022823154929222947
accompanied,0.022823154929222947
authorisations,0.022823154929222947
understandable,0.022823154929222947
hdi,0.022823154929222947
register,0.022823154929222947
includes,0.022823154929222947
competent,0.022823154929222947
refused,0.022823154929222947
registration,0.022823154929222947
manner,0.022823154929222947
exhaustive,0.022823154929222947
parliament,0.022823154929222947
broker,0.022823154929222947
indexed,0.022823154929222947
grounds,0.022823154929222947
laypersons,0.022823154929222947
consented,0.022823154929222947
improving,0.022689637951317426
behaviour,0.022689637951317426
conclusions,0.022689637951317426
display,0.022647819033407728
analysed,0.022647819033407728
rhythm,0.02256411537355521
69,0.02256411537355521
93,0.02256411537355521
identification,0.02256411537355521
justified,0.02256411537355521
painful,0.022383340118754803
settings,0.022383340118754803
ulcers,0.022301804476648934
untreated,0.022301804476648934
pharmacodynamic,0.021436036266104058
46,0.021436036266104058
modulation,0.021436036266104058
furthermore,0.020407196771347443
slower,0.020407196771347443
84,0.020279386659927633
suggests,0.020279386659927633
subsets,0.020279386659927633
terminology,0.020279386659927633
transformation,0.020279386659927633
pathways,0.020279386659927633
treating,0.020279386659927633
waiting,0.020279386659927633
macrophages,0.020279386659927633
framework,0.020197851017821764
soluble,0.020197851017821764
ministere,0.020025463493051857
lost,0.020025463493051857
2006,0.020025463493051857
scanner,0.020025463493051857
plasmatic,0.020025463493051857
achieved,0.019572157902870247
situations,0.019572157902870247
102,0.01925054716517102
121,0.01925054716517102
naming,0.01907815964040111
1055,0.01907815964040111
140,0.01907815964040111
comparative,0.01907815964040111
rao,0.01907815964040111
sr,0.01907815964040111
unimportant,0.01907815964040111
tender,0.01907815964040111
592,0.01907815964040111
governing,0.01907815964040111
website,0.01907815964040111
ca,0.01907815964040111
city,0.01907815964040111
feature,0.01907815964040111
semicolon,0.01907815964040111
add,0.01907815964040111
relating,0.01907815964040111
funders,0.01907815964040111
ja,0.01907815964040111
jp,0.01907815964040111
institution,0.01907815964040111
hogan,0.01907815964040111
sm,0.01907815964040111
institutions,0.01907815964040111
postcode,0.01907815964040111
separated,0.01907815964040111
engl,0.01907815964040111
possibility,0.018624854050219502
aid,0.018624854050219502
3n,0.018624854050219502
641,0.018624854050219502
013,0.018624854050219502
multivariate,0.018624854050219502
immunologie,0.017921510034224687
external,0.017468204444043078
carry,0.017468204444043078
expertise,0.017468204444043078
73,0.017468204444043078
meaningful,0.017468204444043078
induces,0.015323201437666658
ya,0.015323201437666658
auxiliary,0.015323201437666658
signal,0.014166551831490234
marker,0.014166551831490234
distribution,0.014166551831490234
2024,0.014166551831490234
class,0.014166551831490234
monocytes,0.014166551831490234
origin,0.013219247978839487
supported,0.013219247978839487
129,0.013219247978839487
cytometry,0.013219247978839487
partially,0.013219247978839487
memory,0.013219247978839487
flow,0.013219247978839487
depend,0.013219247978839487
117,0.013219247978839487
